Effect of androgen deprivation on epithelial and mesenchymal tissue components in localized prostate cancer

British Journal of Urology

Volumn 79, Issue 3, 1997, Pages 421-426

  Hellstrom M ^a,d   Ranefall, P ^a,b   Westerf, K ^a,b   Brandstedt S ^a,c   Busch, C ^a,b  

^a DANDERYD HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cancer volume; Colour image analysis; Immunohistochemistry; Localized prostate cancer; Neoadjuvant androgen deprivation; Planimetry

Indexed keywords

ANDROGEN; CYPROTERONE ACETATE; HYPOTHALAMUS RELEASING FACTOR; TRIPTORELIN;

ARTICLE; CLINICAL ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SMOOTH MUSCLE;

EID: 0031397170     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1997.02920.x     Document Type: Article

References (26)

1. Häggman M, Hellström M, Aus G et al. Neoadjuvant GnRHagonist treatment (triptorelin and cyproterone acetate for flare protection) and total prostatectomy. Eur Urol 1993; 24: 456-60
2. Varenhorst E, Berglund K, Lof'man 0. Pedersen KV. Interobserver variation in the assessment of the prostate by digital rectal examination by the urologist and the general practitioner -analysis using kappa-statistics. Br }Urol 1993: 72: 173-6
3. Norberg M, Häggman M, Andersson T. Busch C. Magnusson A. Evaluation of localized prostate cancer -a comparative study of transrectal ultrasonography versus histopathology. Eur Radial 1993: 3: 166-73
4. Partin A. Epstein J, Cho K. Gittelsohn A, Walsh P. Morphometric measurements of volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. / Urol 1989: 141: 341-5
5. Willemse F, Nap M, Eggink HF. Foekens JA, HenzenLogmans SC, van Putten WLJ. Quantification of relative area of pS2 immunohistochemical staining and epithelial percentage in breast carcinomas: the effect of the latter on the interpretation of a cytosolic pS2 assay. Modern Pathol 1995; 8: 521-5
6. Häggman M. Norberg M, de la Torre M. Fritjofsson A, Busch C. Characterization of localized prostatic cancer. Distribution, grading and pT-staging in total prostatectomy spécimens. Scand }Urol Nephrol 1993; 27: 7-13
7. Collins AT. Zhiming B, Gilmore K. Neal DE. Androgen and oestrogen responsiveness of stromal cells derived from the human hyperplastic prostate: oestrogen regulation of the androgen receptor. / Endocrinol 1994; 143: 269-77
8. Walsh PC. Lepor H. Eggleston JC. Radical prostatectomy with preservation of sexual function, anatomical and pathological considerations. Prostate 1983; 4: 473-85
9. Hellström M. Häggman M. Brändstedt S et al. Histopathological changes in androgen-deprived localized prostatic cancer. A study in total prostatectomy spécimens. Eur Urol 1993: 24: 461-5
10. Häggman M, de la Torre M. Norberg M, Busch C. Preoperative histological and cytological diagnosis and DNA ploidy assessments of localized prostatic cancer. APMIS 1994; 102: 1-7
11. De la Torre M, Häggman M, Brändstedt S, Busch C. Prostatic intraepithelial neoplasia (PIN) and invasive adenocarcinoma in total prostatectomy spécimens. Br / Urol 1993: 72: 207-13
12. Cattoretti C. Pileri S. Parravicini C et al. Antigen unmasking on formalin-fixed paraffin-embedded tissue sections. / Pathol 1993; 171: 83-98
13. Sweat F. Puchtler H, Rosenthal S. Sirius Red F3BA as a stain for connective tissue. Arch Pathol 1964; 78: 69-72
14. Wilkinson MH. Shading correction and calibration in bacterial fluorescence measurement by image processing system. Comput Methods Programs Biomed 1994: 44: 61-7
15. Ranefall P, Nordin B. Bengtsson E. A new metric in color space used for supervised and unsupervised image segmentation. Proceedings of Swedish Society for Automated Image Analysis: Symposium on Image Analysis, Halmstad, Sweden. March 8-9. 1994: 77-80
16. Bengtsson E, Nordin B, Pedersen F. MUSE -a new tool for image segmentation based on multivariate statistics. In Computer Methods and Programs in Biomedicine 42. Amsterdam: Elsevier. 1994: 181-200
17. Hedley DW. Friedlander ML. Taylor IW. Rugg CA. Musgrove EA. Method for analysis of cellular DNA content of paraffinembedded material using flow cytometry. / Histochem Cytochem 1983: 31: 1333-5
18. Malmström P-U. Vasko J. Wester K, Norlén BJ. Busch C. Flow cytometric analysis of DNA content of deparafflnized nuclei in urinary bladder carcinomas. APM1S 1989; 97: 811-19
19. Hellström M, Wester K. Häggman M. Brändstedt S. Busch C. DNA ploidy patterns in androgen-deprived localized prostate cancer. Eur Urol 1996; 229: 420-4
20. Willemse F, Nap M, de Kok LB, Eggink HF. Image analysis in immunohistochemistry: factors with possible influence on thé performance of VIDAS 2.0. a commercially available true color image analysis system. Analyt Quant Cytol Histol 1993: 15: 136-43
21. Duda R, Hart P. Pattern Classification and Scene Analysis. New York: Wiley. 1973: 24-30
22. Griffiths K. Akaza H, Eaton CL et al. Hormones, growth factors and benign prostatic hyperplasia (BPH). In Cockett AT, Aso Y, Chatelin C et al. eds, Proceedings of The International Consultation on Benign Prostatic Hyperplasia (BPH). Paris: Scientific Communications Institute. 1991: 25-49
23. Janssen PJ, Brinkmann AO, Boersma WJ. Van der Kwast TH. Immunohistochemical detection of the androgen receptor with monoclonal antibody F39.4 in routinely processed, paraffin-embedded human tissues after microwave pre-treatment. / Histochem Cytochem 1994; 42: 1169-75
24. Griffiths K. Akaza H, Eaton CL et al. Regulation of prostatic growth. In Cockett AT, Aso Y, Chatelin C et al. eds, Proceedings of The International Consultation on Benign Prostatic Hyperplasia (BPH). Paris: Scientific Communications Institute, 1991: 49-75
25. Schulman CC. Neoadjuvant androgen blockade prior to prostatectomy: a retrospective study and critical review. Prostate (Suppl) 1994; 5: 9-14
26. Brawer MK, Deering RE, Brown M. Preston SD, Bigler SA. Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity. Cancer 1994; 73: 678-87